• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

Worldwide Point of Care (POC): Are Decentralized Clinical Diagnostics a Cost Drain or Revenue Driver?

$1,500.00 – $5,990.00

Clear
SKU: KLI1362425 Categories: Diagnostics Market Research, Point-of-Care Diagnostics Pages: 300
  • Description
  • Table of Contents
  • Latest reports

Description

This report takes a bold look into the markets, technologies, and trends in decentralized testing with a special focus on the economics of rapid test use in critical care and emergency medicine. There is also an emphasis on early disease detection via rapid test use in clinics and public venues. The report is conservative in its predictions and offers a calculated look into the future, based on events currently taking place.

The field for rapid test devices is crowded; worldwide, more than 100 companies market rapid tests using the whole gamut of instruments and technologies that reduce test times to hours or minutes in some cases. Growth in POC testing is fueled by the increasing numbers of diagnosed diabetics, people with cardiovascular disease, and other chronic conditions. It is also part of a trend in health care to evaluate provider organizations for quality in care delivery. While this quality imperative is most apparent in pay-for-performance systems, it also provides a framework by which public funds can be used more rationally. All countries are feeling the brunt of aging populations and an increased burden of chronic disease management.

The report offers a quantitative assessment of specific markets in US dollars for 2005 to 2015. These data are provided in order to set the status quo of tests and technologies. However the report concentrates on how these will impact the economics of healthcare over the near term and longer when possible.

Table of Contents

Chapter One: Executive Summary

  • Introduction
  • Scope and Methodology
  • Size and Growth of the Market
  • Market Trends

Chapter Two: Introduction

  • Background
  • Miniaturization, digitization and informatics
  • The pros and cons of POC testing
  • Point of View

Chapter Three: Market and Technological Dynamics

  • Background
  • The emergence of non-invasive technologies
  • Pharmacogenomics (PGx) on Demand
  • Lab-on-a-Chip
  • The Wireless Revolution
  • Connectivity Imperative
  • Non-Invasive Sampling
  • Regulatory environment

Chapter Four: The Economics of POC Testing: Revenue Opportunity

  • Background
  • POC and Clinical Outcomes Management
  • POC and Organization Culture Change
  • POC in the Management of Critical Care Patients
  • Reimbursement Trends
  • Migration of POC to the Core Lab: The Lab Fights Back
  • More than Device Installation: Training and QC

Chapter Five: Market Analysis

  • Market Overview
  • POC in World Markets
  • The Major Players
  • Over-the-Counter (OTC) Tests
  • Physician Office Labs (POLs) and Clinic Testing for Early Disease Detection
  • POC Testing in the Hospital
  • Home Monitoring of Individuals with Chronic Diseases
  • POC Test Segments
    • Blood Glucose
    • Cardiac markers
    • Clinical Chemistry/Hematology
    • Coagulation
    • Critical care analytes – Blood Gas/Electrolytes
    • Drugs of Abuse
    • Infectious Diseases
    • Pharmacogenetics
    • Pregnancy/Fertility
    • Sepsis
    • Oncology
    • Women’s health
    • Urinalysis
  • Emerging Tests and Technologies
  • Commercial Outlook

Chapter Six: Company Briefs

  • The Top IVD Companies and Their POC Offerings
    • Abbott Laboratories
    • Bayer Corporation / Siemens
    • Beckman-Coulter Diagnostics
    • bioMerieux Inc.
    • Dade Behring Inc.
    • Daiichi Pure Chemicals Co., Ltd.
    • Instrumentation Laboratory (IL)
    • Roche Diagnostics
  • POC Companies and New Frontiers
    • Abaxis Inc.
    • Abbott Diagnostics
    • Accumetrics, Inc.
    • Accurex Biomedical, Pvt., Ltd
    • Actimed Diagnostics
    • Adeza Biomedical Corporation
    • Aerscher Diagnostics
    • Akers Bioscience
    • Ambri Ltd
    • American Bio Medica Corp.
    • American Biogenetic Sciences, Inc
    • Ani Biotech
    • Ark Therapeutics
    • Array Medical
    • Avitar, Inc.
    • Avox Systems
    • Axis-Shield
    • Bayer Corporation
    • Beacon Diagnostics
    • Biex Inc.
    • Binax Corporation
    • Biomerica
    • BioMérieux Vitek, Inc.
    • BioScan Screening Systems, Inc.
    • Biosite Diagnostics
    • Biostar
    • Caliper Technologies
    • Calypte Biomedical
    • Cardiovascular Diagnostics (Pharmanetics)
    • Cholestech
    • Chongqing Sungene Pharmaceutical Co., Ltd
    • Compucyte Corporation
    • Cortech Ltd.
    • Cozart Biosciences
    • Cygnus Therapeutic Systems
    • Cytogen
    • Dade Behring
    • Denka Seiken Co., Ltd.
    • Diagnology, Inc.
    • Diametrics Medical, Inc.
    • Disetronic Medical Systems
    • Dynagen
    • Ely Labs
    • Enterix, Inc.
    • GDS Technology GenBio
    • Genzyme Diagnostics
    • Gryphus Diagnostics
    • Helena Laboratories
    • Hemocue, Inc.
    • Home Access Health Corp
    • Iatron
    • Immunoscience, Inc.
    • Instrumentation Laboratory
    • International Medical Innovations
    • Inverness
    • i-Stat Corporation
    • Jiangnan Biotech
    • Johnson & Johnson
    • Kyowa Medex Co., Ltd.
    • LifeAssays
    • LifePoint, Inc.
    • LifeScan Corporation
    • Lifestream Technologies 266
    • LXN Corp (Inverness Medical Technologies)
    • Matritech
    • Medical Services International Inc.
    • Medisense
    • Medix Biochemica
    • MedMira Laboratories
    • Medtronic Cardiac Surgery (ACT)
    • Medtronic
    • Meretek Corporation
    • Meridian Diagnostic
    • Micro Diagnostics Corp
    • MiniMed
    • New Horizons Diagnostics
    • Nova Biomedical
    • Optical Sensors Inc.
    • Orasure
    • Orgenics
    • Orion Diagnostica
    • PanBio Corp
    • Pharmanetics, Inc.
    • Pharmatech Corporation
    • Point of Care Technologies
    • Polymedco
    • Polymer Technology Systems
    • PreMD
    • Princeton BioMeditech Corporation
    • Quidel
    • Radiometer
    • Rapid Bio Tests Corporation
    • Response Biomedical Corp.
    • Roche Diagnostics
    • Royal Philips Electronics
    • Phillips Medical Systems
    • Saliva Diagnostics
    • Savyon Diagnostics
    • Selfcare, Inc.
    • Seradyn Clinical Diagnostics/Apogent Technologies
    • Shanghai Siic Kehua Biotech Co., Ltd. (Kehua Biotech)
    • Sienco
    • Simplex Medical Systems
    • SmithKline/Beckman Diagnostics
    • Spectral Diagnostics
    • SpectRx, Inc.
    • Stat Site Meter
    • STC Technologies
    • Sun Biomedical Laboratories
    • Sybron International Corporation
    • Taiwan Diagnostic
    • Therasense, Inc.
    • Thoratec/International Technidyne Corp
    • Transmedica
    • Trinity Biotech
    • Wampole Laboratories
    • Worldwide Medical Corporation
    • Wyntek Diagnostics

List of Exhibits

  • Exhibit 1: Market Summary: Worldwide POC Sales 2005-2010
  • Exhibit 2: Selected New Biochip Products (Company, Product, Target)
  • Exhibit 3: U.S. Lab Reimbursement by Recipient (Quest, LabCorp, Other Reference Lab, Hospital Lab, Physician Office Lab), 2005
  • Exhibit 4: World POC OTC Sales by Test Category (Glucose, Pregnancy/Ovulation, Coagulation/PT, Fecal Occult Blood, Drugs Of Abuse, H. Pylori, HIV, Cholesterol, Other) 2005-2010
  • Exhibit 5 World POC Professional Sales by Test Category (Glucose, Critical Care, Pregnancy, Infectious Diseases, Cardiac Markers, Cholesterol/Lipids, Coagulation/PT/ACT, HbA1c, Hemoglobin, Fecal Occult Blood, Drugs of Abuse, Bilirubin, Other) 2005-2010
  • Exhibit 6: POC Test Revenues of Selected IVD Companies (Top 40 Competitors), 2005
  • Exhibit 7: Selected Direct-to-Consumer Tests on the Market
  • Exhibit 8: Selected OTC Test Devices on the Market (Company, Device, Target)
  • Exhibit 9: Selected Professional POC Tests on the Market and in Development (Company, Device, Target, Development Status)
  • Exhibit 10: World Glucose Monitoring Sales and Market Share by Company and Segment (Professional vs OTC), 2005
  • Exhibit 11: Selected Blood Glucose Test Devices on the Market (Company, Product, Development Status)
  • Exhibit 12: HgbA1c Test Market by Setting (Lab vs POC) and Region (United States, Europe, ROW), Revenues, Average Cost per Test, Number of Tests 2005
  • Exhibit 13: Worldwide Sales of Selected Lab Based Cardiac IVDs (Cholesterol/Lipid Markers, CRP/Inflammation Markers, AMI Enzymes, BNP, Homocysteine, D-Dimer), 2005-2010
  • Exhibit 14: Worldwide Sales of Selected Professional POC Cardiac IVDs (Cholesterol/Lipid Markers, AMI Enzymes, BNP, D-Dimer), 2005-2010
  • Exhibit 15: Worldwide Sales of OTC Cholesterol/Lipid Tests, 2005-2010
  • Exhibit 16: Cardiac IVD Testing Volumes by Region (United States, Europe, ROW) and Test (6 Lab-Based Tests, 4 Professional POC Tests, OTC Cholesterol [see Exhibits 13, 14, and 15 for specific tests]), 2005
  • Exhibit 17: PT Testing Volume by Region (United States, Europe, ROW) and Type (Lab, Professional POC, OTC), 2005
  • Exhibit 18: Infectious Disease Testing Volumes by Region (United States, Europe, ROW) and Test (Strep A, Influenza, HIV, Vaginitis, Chlamydia, H. pylori, Meningitis, Mononucleosis, Strep B, Strep. Pneum, Others), 2005
  • Exhibit 19: Selected SNP-Drug Interactions
  • Exhibit 20: Fecal Occult Blood (FOB) Testing Volumes by Region (United States, Europe, ROW) and Type (POC Professional Guaiac, POC Professional Immunochemical, OTC Guaiac/immuno, OTC Flushable), 2005
  • Exhibit 21: Women’s Health Testing Volumes by Region (United States, Europe, ROW) and Type (Professional Pregnancy, OTC Pregnancy, OTC LH/Ovulation), 2005
  • Exhibit 22: Selected OTC Non-Pregnancy Women’s Health and Fertility Tests on the Market

 

    Global Immunoassay Market: Trends, Technologies, and Growth Opportunities, 2025
    June 12, 2025
    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025

Related products

  • Placeholder image

    The Worldwide Market for In Vitro Diagnostic Tests, 5th Edition

    $3,900.00 – $7,800.00
  • Placeholder image

    Molecular Diagnostics for Pharmacogenetic Testing: Testing volume, cost per test, and market potential

    $995.00 – $1,990.00
  • Placeholder image

    Diagnostics for Emerging Infectious Disease Threats Volume III: Bacterial Disease

    $1,995.00 – $3,990.00
  • Placeholder image

    U.S. Market for Over-the-Counter Diagnostics: Product Sales and Consumer Survey, The

    $4,995.00 – $9,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
Medical Imaging Markets, Volume III – UltrasoundClinical Diagnostics in India – Market Sector Analyses and Participant...
Scroll to top